Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Significant Functional Improvement in a Person with Multiple Sclerosis Utilizing Dynamic Neuromuscular Stabilization: 1333 June 2, 8: 00 AM - 8: 20 AM.
Compromised blood-brain barrier permeability: Novel mechanism by which circulating angiotensin II signals sympathoexcitatory centers during hypertension.
β cell ER stress and the implications for immunogenicity in type 1 diabetes.
How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
Drinking away fatigue in multiple sclerosis.
Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.
Brain white matter changes in CPAP-treated obstructive sleep apnea patients with residual sleepiness.
Social cognition in multiple sclerosis: A systematic review and meta-analysis.
Development and characterization of a human embryonic stem cell-derived 3D neural tissue model for neurotoxicity testing.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms.
Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.
Impact of multiple sclerosis on employment and use of job-retention strategies: The situation in France in 2015.
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients.
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.
OMIP-033: A comprehensive single step staining protocol for human T- and B-cell subsets.
Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats.
Corrigendum to "Evolution of diagnostic criteria for multiple sclerosis" [Pol. J. Neurol. Neurosurg. 49 (5) (2015) 313-321].
Protective Effect of Low-Intensity Pulsed Ultrasound on Memory Impairment and Brain Damage in a Rat Model of Vascular Dementia.
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis.
A new approach to follow a single extracellular vesicle-cell interaction using optical tweezers.
Structural brain indices and executive functioning in multiple sclerosis: A review.
Pages
« first
‹ previous
…
806
807
808
809
810
811
812
813
814
…
next ›
last »